CONCLUSIONS: This study constitutes the first systematic validation of the SNAP-IV in amblyopic children, thereby establishing its robustness for AD/HD screening in visually impaired populations. The scale’s standardized application has the potential to enhance the screening of early AD/HD-amblyopia comorbidity and the development of multidisciplinary intervention strategies for integrating visual and behavioral rehabilitation.
